# Acceptance and Commitment Therapy in SSRI-Resistant Obsessive Compulsive Disorder

> **NCT02955654** · NA · WITHDRAWN · sponsor: **Shanghai Mental Health Center**

## Conditions studied

- Obsessive-Compulsive Disorder

## Interventions

- **BEHAVIORAL:** Acceptance and commitment therapy
- **DRUG:** Aripiprazole
- **BEHAVIORAL:** Stress management training

## Key facts

- **NCT ID:** NCT02955654
- **Lead sponsor:** Shanghai Mental Health Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-09-01
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Loss of finacial support
- **Last updated:** 2022-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02955654

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02955654, "Acceptance and Commitment Therapy in SSRI-Resistant Obsessive Compulsive Disorder". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02955654. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*